Literature DB >> 23697465

Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey.

May A Beydoun1, Hind A Beydoun, Monal R Shroff, Melissa H Kitner-Triolo, Alan B Zonderman.   

Abstract

BACKGROUND: Helicobacter pylori seropositivity is a potential risk for poor cognition among US adults.
METHODS: Cross-sectional data from the National Health and Nutrition Examination Survey III, Phase 1 (1988-1991), were used. Measures included age group-specific neuropsychological test batteries and two measures of H. pylori seropositivity (immunoglobulin G [IgG] and IgG CagA) (20-59 years old: n = 2090-2,248; 60-90 years old: n = 2123-2388). We explored sex- and race-specific associations.
RESULTS: Using multiple ordinary least square and zero-inflated Poisson regression models, we detected a poorer performance among those 60-90 years old with H. pylori IgG+ versus IgG- on a verbal memory test (story recall, correct items), overall (β = -0.04 [0.01], p = .010). Non-Hispanic (NH) blacks and women (20-59 years old) performed worse on the serial digits learning total errors (SDL-TE) when H. pylori IgG+ (versus IgG-), another verbal memory test (β = +0.94 [0.40; p = .029] and β = +1.19 [0.44; p = .012], respectively; p<.10 for interaction by sex and race). More trials to completion on this test (SDL-TTC) were also required among H. pylori IgG+ overall (20-59 years old; β = +0.30 [0.13], p = .033). Other race-specific associations without significant interaction by race were detected in the same direction of worse performance with seropositivity in all three major race groups and for both age categories, covering several domains of cognition.
CONCLUSIONS: H. pylori seropositivity markers were associated with poor cognition among US adults. Longitudinal research is needed to extrapolote those findings to cognitive decline, incident dementia, and Alzheimer's disease.

Entities:  

Keywords:  Helicobacter pylori; adults; aging; cognitive function; seropositivity

Mesh:

Substances:

Year:  2013        PMID: 23697465      PMCID: PMC3679320          DOI: 10.1097/PSY.0b013e31829108c3

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  38 in total

1.  Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results.

Authors:  Claire Roubaud-Baudron; Pierre Krolak-Salmon; Isabelle Quadrio; Francis Mégraud; Nathalie Salles
Journal:  Neurobiol Aging       Date:  2011-12-01       Impact factor: 4.673

2.  A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathobiology and course.

Authors:  Jannis Kountouras; Marina Boziki; Christos Zavos; Emmanuel Gavalas; Evangelia Giartza-Taxidou; Ioannis Venizelos; Georgia Deretzi; Nikolaos Grigoriadis; Elena Tsiaousi; Elizabeth Vardaka
Journal:  Neurobiol Aging       Date:  2012-02-09       Impact factor: 4.673

Review 3.  Epidemiology of dementia and Alzheimer's disease.

Authors:  H C Hendrie
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

4.  Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.

Authors:  Yonatan H Grad; Marc Lipsitch; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-11-15       Impact factor: 4.897

5.  Helicobacter pylori and Alzheimer's disease: a possible link.

Authors:  Mariano Malaguarnera; Rita Bella; Giovanna Alagona; Raffaele Ferri; Anna Carnemolla; Giovanni Pennisi
Journal:  Eur J Intern Med       Date:  2004-10       Impact factor: 4.487

6.  Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients.

Authors:  Jannis Kountouras; Marina Boziki; Emmanouel Gavalas; Christos Zavos; Georgia Deretzi; Stavros Chatzigeorgiou; Panagiotis Katsinelos; Nikolaos Grigoriadis; Evangelia Giartza-Taxidou; Ioannis Venizelos
Journal:  Cogn Behav Neurol       Date:  2010-09       Impact factor: 1.600

7.  Association between Helicobacter pylori infection and mild cognitive impairment.

Authors:  J Kountouras; M Tsolaki; M Boziki; E Gavalas; C Zavos; C Stergiopoulos; N Kapetanakis; D Chatzopoulos; I Venizelos
Journal:  Eur J Neurol       Date:  2007-09       Impact factor: 6.089

8.  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.

Authors:  Jannis Kountouras; Marina Boziki; Emmanuel Gavalas; Christos Zavos; Georgia Deretzi; Nikolaos Grigoriadis; Magda Tsolaki; Dimitrios Chatzopoulos; Panagiotis Katsinelos; Dimitrios Tzilves; Athina Zabouri; Ifigenia Michailidou
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

9.  European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test.

Authors:  A Leodolter; D Vaira; F Bazzoli; K Schütze; A Hirschl; F Mégraud; P Malfertheiner
Journal:  Aliment Pharmacol Ther       Date:  2003-11-01       Impact factor: 8.171

10.  The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

Authors:  Douglas Mapel; Melissa Roberts; Andrew Overhiser; Andrew Mason
Journal:  Helicobacter       Date:  2012-09-04       Impact factor: 5.753

View more
  17 in total

Review 1.  Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children.

Authors:  Li-Jing Xiong; Meng Mao
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 2.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation.

Authors:  Dulciene M M Queiroz; Andreia M C Rocha; Jean E Crabtree
Journal:  Gut Microbes       Date:  2013-08-28

4.  The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis.

Authors:  Brad D Pearce; Deanna Kruszon-Moran; Jeffrey L Jones
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-30       Impact factor: 4.328

Review 5.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

6.  Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.

Authors:  May A Beydoun; Hind A Beydoun; Martine Elbejjani; Gregory A Dore; Alan B Zonderman
Journal:  Alzheimers Dement       Date:  2018-06-28       Impact factor: 21.566

7.  Helicobacter pylori, periodontal pathogens, and their interactive association with incident all-cause and Alzheimer's disease dementia in a large national survey.

Authors:  May A Beydoun; Hind A Beydoun; Jordan Weiss; Sharmin Hossain; Ziad W El-Hajj; Alan B Zonderman
Journal:  Mol Psychiatry       Date:  2020-05-04       Impact factor: 15.992

8.  Unpacking the 'black box' of total pathogen burden: is number or type of pathogens most predictive of all-cause mortality in the United States?

Authors:  A M Simanek; J B Dowd; A Zajacova; A E Aiello
Journal:  Epidemiol Infect       Date:  2014-12-18       Impact factor: 4.434

9.  Helicobacter pylori seropositivity's association with markers of iron, 1-carbon metabolism, and antioxidant status among US adults: a structural equations modeling approach.

Authors:  May A Beydoun; Greg A Dore; Jose A Canas; Hind A Beydoun; Alan B Zonderman
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

10.  Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases β-amyloid by enhancing expression of presenilin-2.

Authors:  Xiu-Lian Wang; Ji Zeng; Jin Feng; Yi-Tao Tian; Yu-Jian Liu; Mei Qiu; Xiong Yan; Yang Yang; Yan Xiong; Zhi-Hua Zhang; Qun Wang; Jian-Zhi Wang; Rong Liu
Journal:  Front Aging Neurosci       Date:  2014-04-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.